Medicinal Products

Lucentis

Name Lucentis
Active Substance ranibizumab
Prescription na recept
Type of prescription ograničeni recept
Distribution u ljekarni
ATC Code S01LA04
Medicinal product marketed in the Croatia Da
Educational materials
for patients / caregivers
Vodič za bolesnike - dijabetička retinopatija ili dijabetički makularni edem, verzija 1
Vodič za bolesnike neovaskularizacia žilnice, verzija 4
Vodič za bolesnike neovaskularna senilna makularna degeneracija, verzija 4
Vodič za bolesnike začepljenje vene u pozadini mrežnice, verzija 4
Vodiče za bolesnike dijabetički makularni edem, verzija 4

Note

The medicinal product has been authorised via centralised procedure in all Member States of the European Union based on the European Medicines Agency's expert opinion. Additional information on the medicinal product can be found under the following link:https://www.ema.europa.eu/en/medicines/human/EPAR/lucentis

The marketing authorisation has been granted by the European Commission. All marketing authorisations of the European Commission can be found under the following link: http://ec.europa.eu/health/documents/community-register/html/index_en.htm

Back